Fernando L. Merino, MD, FACP
Dr. Fernando Merino is an Assistant Professor of Medicine in the Division of Infectious Diseases, Department of Medicine, at the University of Kansas Health System.
Dr. Merino received his MD degree from the Universidad del Pais Vasco, in Spain. After graduation from Medical School, he obtained a Master’s degree in Tropical Medicine at the University of Valencia, in Spain.
His training in Internal Medicine took place at Tuft University’s Newton Wellesley Hospital in Massachusetts. After that, he completed subspecialty training in Infectious Diseases at Yale University in New Haven, Connecticut.
Before moving to Kansas in 2007, he practiced in two Community Hospitals in the States of Texas and New York. He served in both hospitals as Chief of Infectious Diseases, and Chair of the Infection Control and Antibiotic Stewardship committees.
Dr Merino has extensive clinical experience, both treating infections that require hospital admission and those diseases that can be managed on outpatient basis. His main interests are Infections of the Central Nervous System, HIV disease, viral hepatitis, infections in immunocompromised patients, bone and joint infections, diseases caused by Streptococcus pneumoniae, and vaccine-preventable diseases.
Dr Merino is Board-certified in Infectious Disease. He is a member of the Infectious Diseases Society of America, and also a Fellow of the American College of Physicians.
Education and Training
- MD, Medicine, Universidad del Pais Vasco
- Internship, Internal Medicine, Newton-Wellesley Hospital, Tufts University , Newton, MA
Licensure, Accreditations & Certifications
- Infectious Diseases, American Board of Internal Medicine
- Infectious Disease Society of America, Member, 1994 - 2019
Dr. Merino’s main interest is with in the field of clinical research in Infectious Diseases. While doing his residency training in Internal Medicine, Dr. Merino led a 3-year research study on Bacteremia in a Community Hospital.
During his time at Yale University, his Fellowship research project was part of a large research study of tuberculosis in HIV-infected individuals.
Since he came to Kansas, he has collaborated with Infectious Diseases Pediatricians at Mercy Children’s Hospital in a long study of the Pneumococcal vaccines that were initially used for the pediatric population only. During the study time, the use of those vaccines was expanded to adult populations.
He has also participated in research projects looking at the efficacy of new treatments for a range of diseases, including HIV, as well as vaccine-preventable diseases.
He regularly mentors medical students, residents and fellows.